Prof. Paulus Kirchhof FESC, FRCP (Ed)Professor of Cardiovascular Medicine, Institute of Cardiovascular Sciences, University of Birmingham, SWBH and UHB NHS Trusts, Birmingham, United Kingdom
Professor Kirchhof researches mechanisms and management of cardiovascular diseases with a special interest in atrial fibrillation and cardiomyopathies. He has published > 250 peer reviewed papers. He leads a translational research group in Birmingham that works across the university and its major NHS partners (UHB and SWBH). He also has a long-standing experience in the planning and conduct of international multi-centre investigator-initiated trials, including work as Chief Investigator, steering committee member, and data monitoring committee member. His research is funded by British Heart Foundation, Leducq Foundation, European Union, and others. Working closely with international collaborators, his research group uses genetically modified models, controlled clinical trials and trial data bases, imaging data and biosamples from trial participants, and observational cohorts in a translational team approach to science and health care. He uses these resources to improve the management of patients with atrial fibrillation and cardiomyopathies, to develop personalized therapies for AF patients, and to improve cardiovascular health in general.
Professor Kirchhof is an enthusiastic teacher, regular supervisor for MD and PhD students (over 20 completed MD and PhD degrees), and a sought-after speaker. He helps to coordinate cardiovascular curricula in Medicine and post-graduate courses in cardiovascular medicine, contributes to major textbooks in the field, and serves as educational supervisor for medicine and cardiology trainees in Birmingham. Professor Kirchhof runs a large atrial fibrillation service based at SWBH NHS trust and coordinates the interdisciplinary Inherited Cardiac Conditions Clinic at UHB NHS trust.
PK has received research support from European Union, British Heart Foundation, Leducq Foundation, Medical Research Council (UK), and German Centre for Heart Research, from several drug and device companies active in atrial fibrillation, and has received honoraria from several such companies. In addition, Dr. Kirchhof is listed as inventor on two patents held by University of Birmingham (Atrial Fibrillation Therapy WO 2015140571, Markers for Atrial Fibrillation WO 2016012783).